Structural Brain MR Imaging Alterations in Patients with Systemic Lupus Erythematosus with and without Neuropsychiatric Events

References

1. 1.↵
   1. Fanouriakis A,
   2. Tziolos N,
   3. Bertsias G, et al

   . Update on the diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis 2020;80:14–25 doi:10.1136/annrheumdis-2020-218272 pmid:33051219

   Abstract/FREE Full Text
2. 2.↵
   1. Tian J,
   2. Zhang D,
   3. Yao X, et al

   . Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. Ann Rheum Dis 2022;82:351–56 doi:10.1136/ard-2022-223035 pmid:36241363

   Abstract/FREE Full Text
3. 3.↵
   1. Jeltsch-David H,
   2. Muller S

   . Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers. Nat Rev Neurol 2014;10:579–96 doi:10.1038/nrneurol.2014.148 pmid:25201240

   CrossRefPubMed
4. 4.↵
   1. Popescu A,
   2. H. Kao A

   . Neuropsychiatric systemic lupus erythematosus. Curr Neuropharmacol 2011;9:449–57 doi:10.2174/157015911796557984 pmid:22379459

   CrossRefPubMed
5. 5.↵
   1. Sarwar S,
   2. Mohamed AS,
   3. Rogers S, et al

   . Neuropsychiatric systemic lupus erythematosus: a 2021 update on diagnosis, management, and current challenges. Cureus 2021;13:e17969 doi:10.7759/cureus.17969 pmid:34667659

   CrossRefPubMed
6. 6.↵
   1. Chessa E,
   2. Piga M,
   3. Perra A, et al

   . The effect of anti-P ribosomal and anti-NR2 antibodies on depression and cognitive processes in SLE: an integrated clinical and functional MRI study. Lupus Sci Med 2023;10:e001005 doi:10.1136/lupus-2023-001005 pmid:37918951

   Abstract/FREE Full Text
7. 7.↵
   1. Piga M,
   2. Peltz MT,
   3. Montaldo C, et al

   . Twenty-year brain magnetic resonance imaging follow-up study in systemic lupus erythematosus: factors associated with accrual of damage and central nervous system involvement. Autoimmun Rev 2015;14:510–16 doi:10.1016/j.autrev.2015.01.010 pmid:25617815

   CrossRefPubMed
8. 8.↵
   1. Postal M,
   2. Lapa AT,
   3. Reis F, et al

   . Magnetic resonance imaging in neuropsychiatric systemic lupus erythematosus: current state of the art and novel approaches. Lupus 2017;26:517–21 doi:10.1177/0961203317691373 pmid:28394232

   CrossRefPubMed
9. 9.↵
   1. Zhang Z,
   2. Wang Y,
   3. Shen Z, et al

   . The neurochemical and microstructural changes in the brain of systemic lupus erythematosus patients: a multimodal MRI study. Sci Rep 2016;6:19026 doi:10.1038/srep19026 pmid:26758023

   CrossRefPubMed
10. 10.↵
    1. Appenzeller S,
    2. Amorim BJ,
    3. Ramos CD, et al

    . Voxel-based morphometry of brain SPECT can detect the presence of active central nervous system involvement in systemic lupus erythematosus. Rheumatology (Oxford) 2007;46:467–72 doi:10.1093/rheumatology/kel255 pmid:16901949

    CrossRefPubMed
11. 11.↵
    1. Ota Y,
    2. Srinivasan A,
    3. Capizzano AA, et al

    . Central nervous system systemic lupus erythematosus: pathophysiologic, clinical, and imaging features. Radiographics 2022;42:212–32 doi:10.1148/rg.210045 pmid:34990324

    CrossRefPubMed
12. 12.↵
    1. Magro-Checa C,
    2. Beaart-van de Voorde LJ,
    3. Middelkoop HA, et al

    . Outcomes of neuropsychiatric events in systemic lupus erythematosus based on clinical phenotypes; prospective data from the Leiden NP SLE cohort. Lupus 2017;26:543–51 doi:10.1177/0961203316689145 pmid:28394225

    CrossRefPubMed
13. 13.↵
    1. Mak A,
    2. Ho RC,
    3. Tng HY, et al

    . Early cerebral volume reductions and their associations with reduced lupus disease activity in patients with newly-diagnosed systemic lupus erythematosus. Sci Rep 2016;6:22231 doi:10.1038/srep22231 pmid:26928214

    CrossRefPubMed
14. 14.↵
    1. Sarbu N,
    2. Toledano P,
    3. Calvo A, et al

    . Advanced MRI techniques: biomarkers in neuropsychiatric lupus. Lupus 2017;26:510–16 doi:10.1177/0961203316674820 pmid:28394230

    CrossRefPubMed
15. 15.↵
    1. Cox JG,
    2. de Groot M,
    3. Cole JH, et al

    . A meta-analysis of structural MRI Physician Global Assessment studies of the brain in systemic lupus erythematosus (SLE). Clin Rheumatol 2022;42:319–26 doi:10.1007/s10067-022-06482-8 pmid:36534349

    CrossRefPubMed
16. 16.↵
    1. Chessa E,
    2. Piga M,
    3. Floris A, et al

    . Use of Physicians Global Assessment in systemic lupus erythematosus: a systematic review of its psychometric properties. Rheumatology (Oxford) 2020;59:3622–32 doi:10.1093/rheumatology/keaa383 pmid:32789462

    CrossRefPubMed
17. 17.↵
    1. Gladman DD,
    2. Ibañez D,
    3. Urowitz MB

    . Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002;29:288–91

    Abstract/FREE Full Text
18. 18.↵
    1. Gladman DD,
    2. Goldsmith CH,
    3. Urowitz MB, et al

    . The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for systemic lupus erythematosus international comparison. J Rheumatol 2000;27:373–76 pmid:10685799

    PubMedWeb of Science
19. 19.↵
    1. Cocco C,
    2. Manca E,
    3. Corda G, et al

    . Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus. Front Immunol 2023;14:1157149 doi:10.3389/fimmu.2023.1157149 pmid:37383228

    CrossRefPubMed
20. 20.↵
    The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599–608 doi:10.1002/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F pmid:10211873

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Babayan A,
    2. Erbey M,
    3. Kumral D, et al

    . A mind-brain-body dataset of MRI, EEG, cognition, emotion, and peripheral physiology in young and old adults. Sci Data 2019;6:180308 doi:10.1038/sdata.2018.308 pmid:30747911

    CrossRefPubMed
22. 22.↵
    1. Manjón JV,
    2. Romero JE,
    3. Vivo-Hernando R, et al

    . vol2Brain: a new online pipeline for whole brain MRI analysis. Front Neuroinform 2022;16:862805 doi:10.3389/fninf.2022.862805 pmid:35685943

    CrossRefPubMed
23. 23.↵
    1. Yee CS,
    2. Farewell VT,
    3. Isenberg DA, et al

    . The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients. Rheumatology (Oxford) 2011;50:982–88 doi:10.1093/rheumatology/keq376 pmid:21245073

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Unterman A,
    2. Nolte JES,
    3. Boaz M, et al

    . Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis. Semin Arthritis Rheum 2011;41:1–11 doi:10.1016/j.semarthrit.2010.08.001 pmid:20965549

    CrossRefPubMed
25. 25.↵
    1. Roldan P,
    2. Jung RE,
    3. Sibbitt WL, et al

    . Correlation of neurocognitive function and brain lesion load on magnetic resonance imaging in systemic lupus erythematosus. Rheumatol Int 2018;38:1539–46 doi:10.1007/s00296-018-4080-7 pmid:29948000

    CrossRefPubMed
26. 26.↵
    1. Cagnoli P,
    2. Sundgren PC,
    3. Kairys A, et al

    . Changes in regional brain morphology in neuropsychiatric systemic lupus erythematosus. J Rheumatol 2012;39:959–67 doi:10.3899/jrheum.110833 pmid:22467931

    Abstract/FREE Full Text
27. 27.↵
    1. Sârbu N,
    2. Alobeidi F,
    3. Toledano P, et al

    . Brain abnormalities in newly diagnosed neuropsychiatric lupus: Systematic MRI approach and correlation with clinical and laboratory data in a large multicenter cohort. Autoimmun Rev 2015;14:153–59 doi:10.1016/j.autrev.2014.11.001 pmid:25461835

    CrossRefPubMed
28. 28.↵
    1. Mårtensson J,
    2. Rumetshofer T,
    3. Nystedt J, et al

    . Structural changes on MRI demonstrate specific cerebellar involvement in SLE patients: a VBM study. Brain Sciences 2021;11:510 doi:10.3390/brainsci11040510

    CrossRef
29. 29.↵
    1. Buyukdura JS,
    2. McClintock SM,
    3. Croarkin PE

    . Psychomotor retardation in depression: biological underpinnings, measurement, and treatment. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:395–409 doi:10.1016/j.pnpbp.2010.10.019 pmid:21044654

    CrossRefPubMed
30. 30.↵
    1. Blackburn IM

    . Mental and psychomotor speed in depression and mania. Br J Psychiatry 1975;126:329–35 doi:10.1192/bjp.126.4.329 pmid:1148566

    Abstract/FREE Full Text
31. 31.↵
    1. Bennabi D,
    2. Vandel P,
    3. Papaxanthis C, et al

    . Psychomotor retardation in depression: a systematic review of diagnostic, pathophysiologic, and therapeutic implications. BioMed Res Int 2013;2013:158746 doi:10.1155/2013/158746 pmid:24286073

    CrossRefPubMed
32. 32.↵
    1. Conti F,
    2. Ceccarelli F,
    3. Perricone C, et al

    . Systemic lupus erythematosus with and without Anti-dsDNA antibodies: analysis from a large monocentric cohort. Mediators of Inflammation 2015;2015:328078 doi:10.1155;2015:328078 pmid:26063969

    CrossRefPubMed
33. 33.↵
    1. Ter Borg EJ,
    2. Horst G,
    3. Hummel EJ, et al

    . Measurement of increases in anti-double-stranded dna antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. Arthritis Rheum 1990;33:634–43 doi:10.1002/art.1780330505 pmid:2346519

    CrossRefPubMedWeb of Science
34. 34.↵
    1. Rodrigues CEM,
    2. Carvalho JF,
    3. Shoenfeld Y

    . Neurological manifestations of antiphospholipid syndrome. Eur J Clin Invest 2010;40:350–59 doi:10.1111/j.1365-2362.2010.02263.x pmid:20192975

    CrossRefPubMedWeb of Science
35. 35.↵
    1. Kaichi Y,
    2. Kakeda S,
    3. Moriya J, et al

    . Brain MR findings in patients with systemic lupus erythematosus with and without antiphospholipid antibody syndrome. AJNR Am J Neuroradiol 2013;35:100–05 doi:10.3174/ajnr.A3645 pmid:23886740

    Abstract/FREE Full Text
36. 36.↵
    1. Monahan RC,
    2. Inglese F,
    3. Middelkoop H, et al

    . White matter hyperintensities associate with cognitive slowing in patients with systemic lupus erythematosus and neuropsychiatric symptoms. RMD Open 2021;7:e001650 doi:10.1136/rmdopen-2021-001650 pmid:34321253

    Abstract/FREE Full Text
37. 37.↵
    1. Huang CJ,
    2. Zhou X,
    3. Yuan X, et al

    . Contribution of inflammation and hypoperfusion to white matter hyperintensities-related cognitive impairment. Front Neurol 2021;12:786840 doi:10.3389/fneur.2021.786840 pmid:35058875

    CrossRefPubMed
38. 38.↵
    1. Leal Rato M,
    2. Bandeira M,
    3. Romão VC, et al

    . Neurologic manifestations of the antiphospholipid syndrome: an update. Curr Neurol Neurosci Rep 2021;21:41 doi:10.1007/s11910-021-01124-z pmid:34125304

    CrossRefPubMed
39. 39.↵
    1. Arinuma Y,
    2. Kikuchi H,
    3. Wada T, et al

    . Brain MRI in patients with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus. Lupus Sci Med 2014;1:e000050 doi:10.1136/lupus-2014-000050 pmid:25396069

    Abstract/FREE Full Text
40. 40.↵
    1. Tay SH,
    2. Stephenson MC,
    3. Allameen NA, et al

    . Combining multimodal magnetic resonance brain imaging and machine learning to unravel neurocognitive function in non-neuropsychiatric systemic lupus erythematosus. Rheumatology (Oxford) 2024;63:414–22 doi:10.1093/rheumatology/kead221 pmid:37184855

    CrossRefPubMed